Skip to main content

LSL Pharma Group Engages Paradox as Investor Relations Services Provider

Written by Customer Service on . Posted in Public Companies.

BOUCHERVILLE, Québec, Oct. 06, 2023 (GLOBE NEWSWIRE) — LSL Pharma Group Inc. (TSXV: LSL) – (the “Company” or “LSL Pharma Group”), a Canadian integrated pharmaceutical company, is pleased to announce that it has retained on October 5, 2023 the services of Paradox Public Relations Inc. (“Paradox”) to provide investor relations services on behalf of the Company. Paradox is a Montréal-based investor relations consultancy firm that has been in business for over 20 years. Paradox will focus on developing and expanding the Company’s communications and visibility with the investment community through a comprehensive investor relations program.

The Investor Relations Agreement has a term of 12 months and can be terminated at any time without charge by either party by giving 30 days’ notice in writing. Paradox will be paid a monthly fee of $10,000, plus applicable taxes, and are granted stock options to acquire up to 300,000 Class A shares of the Company at a price of $0,70 per share, which options shall be for a period of 10 years and vest in four equal tranches, quarterly over a twelve (12) months period, the whole in accordance with the current stock option plan of the Company and Policy 3.4 of the TSXV. The Investor Relations Agreement as well as the professional engagement fees and granting of the stock options remains subject to TSX Venture Exchange approval.

ABOUT LSL PHARMA GROUP INC.

LSL Pharma Group is a Canadian integrated pharmaceutical company specializing in the development, manufacturing and distribution of high-quality natural health products and dietary supplements in solid dosage forms, as well as high quality sterile ophthalmic pharmaceutical products. For more information, please visit www.laboratoirelsl.com and www.sterimedpharma.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CONTACT:
François Roberge, President and Chief Executive Officer
Telephone: 514-664-7700
Email: Investors@groupelslpharma.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.